Show simple item record

dc.contributor.authorAllen, J
dc.contributor.authorDavid, M
dc.contributor.authorVeerman, JL
dc.date.accessioned2019-06-09T01:36:19Z
dc.date.available2019-06-09T01:36:19Z
dc.date.issued2018
dc.identifier.issn2474-9842
dc.identifier.doi10.1002/bjs5.45
dc.identifier.urihttp://hdl.handle.net/10072/383745
dc.description.abstractBackground: Surgical‐site infections (SSIs) increase the length of hospital admission and costs. SSI prevention guidelines include preoperative antibiotic prophylaxis. This review assessed the reporting quality and cost‐effectiveness of preoperative antibiotics used to prevent SSI. Methods: PubMed, Web of Science, Cumulative Index to Nursing and Allied Health Literature, Index of Economic Articles (EconLit), Database of Abstracts of Reviews of Effect (including the National Health Service Economic Evaluation Database) and Cochrane Central databases were searched systematically from 1970 to 2017 for articles that included costs, preoperative antibiotic prophylaxis and SSI. Included were RCTs and quasi‐experimental studies conducted in Organisation for Economic Co‐operation and Development countries with participants aged at least 18 years and published in English. Two reviewers assessed eligibility, with inter‐rater reliability determined by Cohen's κ statistic. The Consolidated Health Economic Evaluation and Reporting Standards (CHEERS) and modified Drummond checklists were used to assess reporting and economic quality. Study outcomes and characteristics were extracted, and incremental cost‐effectiveness ratios were calculated, with costs adjusted to euros (2016) (€1 = US $1·25; £1 sterling = €1·28). Results: Twelve studies published between 1988 and 2014 were included from 646 records identified; nine were RCTs, two were nested within RCTs and one was a retrospective chart review. Study quality was highest in the nested studies. Cephalosporins (first, second and third generation) were the most frequent prophylactic interventions. Eleven studies demonstrated clinically effective interventions; ten were cost‐effective (the intervention was dominant); in one the intervention was dominated by the control; and in one the intervention was more effective and more expensive than the control. Conclusion: Preoperative antibiotic prophylaxis does reduce SSI, costs to hospitals and health providers, but the reporting of economic methods in RCTs is not standardized. Routinely nesting economic methods in RCTs would improve economic evaluations and ensure appropriate selection of prophylactic antibiotics.
dc.description.peerreviewedYes
dc.languageEnglish
dc.publisherJOHN WILEY & SONS LTD
dc.relation.ispartofpagefrom81
dc.relation.ispartofpageto98
dc.relation.ispartofissue3
dc.relation.ispartofjournalBJS OPEN
dc.relation.ispartofvolume2
dc.subject.fieldofresearchBiomedical Engineering
dc.subject.fieldofresearchcode0903
dc.titleSystematic review of the cost-effectiveness of preoperative antibiotic prophylaxis in reducing surgical-site infection
dc.typeJournal article
dc.type.descriptionC1 - Articles
dc.type.codeC - Journal Articles
dc.description.versionPublished
gro.rights.copyright© 2018 The Authors. BJS Open published by John Wiley & Sons Ltd on behalf of BJS Society Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
gro.hasfulltextFull Text
gro.griffith.authorVeerman, Lennert L.
gro.griffith.authorDavid, Michael


Files in this item

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record